Title: Amino Acids China Monthly Report – July 2026 Commentary
Welcome to the July issue of Amino Acids China Monthly Report.
Governmental direction
Brazil imposed anti-dumping duties on Chinese feed lysine.
Project progress
- The EI report for Grand Huachen's 70,000 t/a glycine project was accepted.
- The EI report for Tianxin Pharma's 7,000 t/a alanine expansion project was publicised.
Company dynamics
- Huaheng Biotechnology halted HKEX IPO following controller's detention.
- Dongxiao Bio's BSE listing application was accepted.
- Meihua Group expected H1 2026 profit to more than halve.
- Sichuan Hebang reported H1 2026 profit up over 600%.
- Adisseo recorded 22.25% YoY net profit growth in H1 2026.
Price update
In July 2026, methionine prices continued to decline, as MHA-FA and solid methionine dropped 10.77% and 19.72% MoM, respectively.
Import and export.
In June 2026, China's export volume and export value of lysine ester and salt increased YoY, whilst the average export price declined.
Reminders
- The USD/CNY exchange rate in this newsletter is USD1.00=CNY6.8067 (sourced from People's Bank of China on 1 July, 2026). All the prices mentioned in this newsletter will include the VAT, unless otherwise specified.
- In this newsletter, the variance rates (MoM, QoQ, YoY, etc.) of all figures that involve RMB/USD conversion (prices, sales values, costs, etc.) are calculated with pre-conversion RMB prices/values, except for the figures in Import and Export column.
Please purchase to view
Buy Now
Add to cart
